21ST CENTURY CURES
Get patients involved early in design of trials, Congress panel advised
By Randy Osborne
Monday, July 14, 2014
The end of a two-part hearing on ways to speed clinical trials and include more diverse populations without introducing risk or mistakes included testimony by Alkermes plc CEO Richard Pops, who used his five minutes to propose a new framework for patients' help with trials that he said "would fundamentally transform the way we approach these [drug] development programs."
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.